Skip to search.
 STI Down 0.65%

Biogen Inc. (BIIB)

-NasdaqGS
285.13 Up 0.38(0.13%) 25 Feb 05:00 SGT
|After Hours : 285.13 0.00 (0.00%) 25 Feb 07:29 SGT
Prev Close:284.75
Open:285.01
Bid:266.06 x 200
Ask:285.15 x 100
1y Target Est:321.72
Beta:0.499955
Earnings Date:19 Apr - 24 Apr (Est.)
Day's Range:266.00 - 285.81
52wk Range:223.02 - 333.65
Volume:1,768,544
Avg Vol (3m):1,790,240
Market Cap:61.57B
P/E (ttm):16.84
EPS (ttm):16.93
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 0.13%61.57B
1 0.00%N/A
PFEUp 0.59%207.90B
ABTUp 0.62%78.85B

Key Statistics

Forward P/E (1 yr):12.66
P/S (ttm):5.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-17) :20.98
Quarterly EPS Est (Mar-17) :5.00
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.16

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc., a biopharmaceutical company, discovers, develops, manufactures, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback